WE INTERFERE
DEAD

Serial Number

88734122

Owner

Dicerna Pharmaceuticals, Inc.

Attorney

Bridget H Labutta

Filing Date

Dec 19, 2019

Add to watchlist:

No watchlists yet
View on USPTO

WE INTERFERE Trademark

Serial Number: 88734122

WE INTERFERE is a trademark filed by Dicerna Pharmaceuticals, Inc. on December 19, 2019. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Dicerna Pharmaceuticals, Inc. (33 trademarks)

Lexington, MA 02421

Entity Type: 03

Trademark Details

Filing Date

December 19, 2019

Registration Date

Not Registered

Published for Opposition

March 31, 2020

Goods & Services

Pharmaceutical preparations for the treatment of various diseases, namely, rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases, cancers, and viral infections; oligonucleotide compounds for use in the targeted delivery of RNAI therapy; pharmaceutical preparations for use in targeted pharmaceutical therapies for the treatment of various diseases, namely, rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases, cancers, and viral infections; chemical compounds in the form of a molecular nanoparticle complex that act as a platform for the delivery of RNA-based drugs to biological cells; drug delivery agents consisting of oligonucleotide compounds that facilitate the delivery of a wide range of pharmaceutical based therapies

Research and development of oligonucleotide compounds for use in targeted pharmaceutical therapies for the treatment of various diseases, namely, rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases, cancers, and viral infections; research and development of pharmaceutical preparations for the treatment of liver-based disorders; research and development of oligonucleotide compounds for targeted gene silencing; scientific research and development; scientific investigations for medical purposes; providing medical and scientific research information in the field of pharmaceuticals and clinical trials

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Jun 26, 2023 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jun 26, 2023 ABN6
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 7, 2023 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 7, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 7, 2023 REAP
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 6, 2022 EXRA
SOU EXTENSION 5 GRANTED
Dec 3, 2022 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Dec 3, 2022 AITU
SOU EXTENSION 5 FILED
Nov 22, 2022 EXT5
SOU TEAS EXTENSION RECEIVED
Nov 22, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 27, 2022 EXRA
SOU EXTENSION 4 GRANTED
May 25, 2022 EX4G
SOU EXTENSION 4 FILED
May 25, 2022 EXT4
SOU TEAS EXTENSION RECEIVED
May 25, 2022 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 25, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 25, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 25, 2022 REAP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 2, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 2, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 2, 2022 REAP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 13, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 13, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 13, 2022 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jan 5, 2022 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 5, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 5, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 5, 2022 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jan 5, 2022 COAR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 19, 2021 EXRA
SOU EXTENSION 3 GRANTED
Nov 17, 2021 EX3G
SOU EXTENSION 3 FILED
Nov 17, 2021 EXT3
SOU TEAS EXTENSION RECEIVED
Nov 17, 2021 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 27, 2021 EXRA
SOU EXTENSION 2 GRANTED
May 25, 2021 EX2G
SOU EXTENSION 2 FILED
May 25, 2021 EXT2
SOU TEAS EXTENSION RECEIVED
May 25, 2021 EEXT
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Feb 25, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 25, 2021 TCCA
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Feb 25, 2021 COAR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 1, 2020 EXRA
SOU EXTENSION 1 GRANTED
Nov 27, 2020 EX1G
SOU EXTENSION 1 FILED
Nov 27, 2020 EXT1
SOU TEAS EXTENSION RECEIVED
Nov 27, 2020 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 26, 2020 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 31, 2020 NPUB
PUBLISHED FOR OPPOSITION
Mar 31, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 11, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 25, 2020 CNSA
ASSIGNED TO EXAMINER
Feb 20, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 28, 2019 NWOS
NEW APPLICATION ENTERED
Dec 23, 2019 NWAP